What PwC Technology Advisory gets wrong in Healthcare
PwC Technology Advisory's approach to Healthcare technology follows the same model that has driven their recent performance problems. PwC Australia government scandal (2023): partner leaked confidential Treasury tax policy to advise corporate clients — government banned from federal contracts, forced to sell government practice for $1
Healthcare technology operates under specific regulatory and operational constraints that generalist consulting firms consistently underestimate. Pharmaceutical technology lives under FDA 21 CFR Part 11. PwC Technology Advisory's model does not account for the domain qualification required to navigate this environment.
Compliance in Healthcare is not a consulting deliverable — it is an architectural constraint. PwC Technology Advisory treats compliance as a separate workstream that produces documentation. The systems that result require significant remediation before they can survive an audit in a healthcare environment.
What we deploy instead
Our healthcare engineering teams are domain-qualified before they are assigned to an engagement. They understand the regulatory framework — FDA 21 CFR PART 11 and HIPAA — as an engineering constraint, not a compliance checklist.
Every system we deploy for a healthcare client is compliant at the infrastructure layer. The architecture enforces the controls. ALICE validates compliance at every commit. The result is a system that passes audits because it was built to, not because documentation was assembled after the fact.
FDA 21 CFR PART 11 and HIPAA built into the architecture from day one — enforced automatically by ALICE at every commit.
Fixed-price engagements. Production system in 8-20 weeks. No discovery phase. No change orders.
Domain-qualified engineers with healthcare experience. The senior engineer who scopes the engagement is the senior engineer who delivers it.
Full source code and documentation transferred at close. No licensing. No managed services dependency.
The compliance difference
FDA 21 CFR PART 11 and HIPAA compliance is an architectural constraint in healthcare. PwC Technology Advisory treats it as a consulting deliverable. We build it into the infrastructure.
What switching from PwC Technology Advisory looks like
A typical healthcare engagement runs 10-20 weeks to a production system. Team: 8-16 engineers, all domain-qualified. Fixed price. Full IP transfer at close.
Architecture review and scope definition. We review existing deliverables and identify gaps.
Scope locked, team assembled, first sprint underway. Working code from week two.
First production milestone — a working integration or system component, not a document.
Full IP transfer. Source code, documentation, operational runbooks. Your team runs the system.
Failed Vendor Recovery Playbook
Step-by-step framework for recovering from a failed PwC Technology Advisory engagement — from emergency stabilisation through full re-platforming. 4-phase playbook covering stabilise, assess, transition, and normalise.